# ANDA209615
> **ANDA209615** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-05-02
## Drug
- **FDA Application Number:** ANDA209615
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** ACTAVIS LABS FL INC
- **First approval:** 2022-05-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209615)
---
*AI Analytics · CC0 1.0*